Phio Pharmaceuticals Corp.
PHIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,392 | -$2,166 | -$1,769 | -$1,626 |
| Dep. & Amort. | $2 | $0 | $0 | $42 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $51 | $43 | $48 |
| Change in WC | $192 | -$425 | $451 | $216 |
| Other Non-Cash | $113 | $0 | $0 | -$51 |
| Operating Cash Flow | -$2,085 | -$2,540 | -$1,275 | -$1,371 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$3 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $9 |
| Investing Cash Flow | -$7 | -$3 | -$2 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,052 | $40 | $9,173 | $1,356 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$30 | $0 | $0 | -$1 |
| Financing Cash Flow | $2,022 | $40 | $9,173 | $1,355 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$70 | -$2,503 | $7,896 | -$8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,775 | $13,278 | $5,382 | $5,390 |
| End Cash | $10,705 | $10,775 | $13,278 | $5,382 |
| Free Cash Flow | -$2,092 | -$2,543 | -$1,277 | -$1,372 |